Page last updated: 2024-08-23

epirubicin and Cancer of Muscle

epirubicin has been researched along with Cancer of Muscle in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Chen, L; Fan, W; Huang, B; Lin, H; Qiu, S; Wang, H; Yao, Z; Zheng, J	1
Adamkiewicz-Drozynska, E; Bien, E; Fatyga, A; Gabrych, A; Izycka-Swieszewska, E; Kazanowska, B; Krawczyk, MA; Kunc, M; Sokolewicz, EM; Styczewska, M	1

Trials

1 trial(s) available for epirubicin and Cancer of Muscle

Article	Year
Evaluation of the effects of intra-arterial chemotherapy combined with intravesical chemotherapy against intravesical chemotherapy alone after transurethral resection of bladder tumor in T1-staged Grade 3 bladder cancer. Journal of cancer research and clinical oncology, 2019, Volume: 145, Issue:2 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Female; Follow-Up Studies; Humans; Injections, Intra-Arterial; Male; Middle Aged; Muscle Neoplasms; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Urinary Bladder Neoplasms	2019

Article

Year

Evaluation of the effects of intra-arterial chemotherapy combined with intravesical chemotherapy against intravesical chemotherapy alone after transurethral resection of bladder tumor in T1-staged Grade 3 bladder cancer.

Journal of cancer research and clinical oncology, 2019, Volume: 145, Issue:2

Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Female; Follow-Up Studies; Humans; Injections, Intra-Arterial; Male; Middle Aged; Muscle Neoplasms; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Urinary Bladder Neoplasms

2019

Other Studies

1 other study(ies) available for epirubicin and Cancer of Muscle

Article	Year
Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2019, Volume: 24, Issue:6 Topics: Adolescent; Antigens, Neoplasm; Biomarkers, Tumor; Biopsy; Carbonic Anhydrase IX; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dactinomycin; Epirubicin; Female; Gene Expression; Glucose Transporter Type 1; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ifosfamide; Infant; Infant, Newborn; Male; Muscle Neoplasms; Neoadjuvant Therapy; Prognosis; Prospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vascular Endothelial Growth Factor A; Vincristine	2019

Article

Year

Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2019, Volume: 24, Issue:6

Topics: Adolescent; Antigens, Neoplasm; Biomarkers, Tumor; Biopsy; Carbonic Anhydrase IX; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dactinomycin; Epirubicin; Female; Gene Expression; Glucose Transporter Type 1; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ifosfamide; Infant; Infant, Newborn; Male; Muscle Neoplasms; Neoadjuvant Therapy; Prognosis; Prospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vascular Endothelial Growth Factor A; Vincristine

2019